Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-073623
Filing Date
2025-08-04
Accepted
2025-08-05 09:19:09
Documents
4
Period of Report
2025-09-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2521566-2_def14a.htm DEF 14A 202093
2 GRAPHIC sg_davidplusi-bw.jpg GRAPHIC 6675
3 GRAPHIC px_25acurxproxy01pg01-bw.jpg GRAPHIC 238263
4 GRAPHIC px_25acurxproxy01pg02-bw.jpg GRAPHIC 213116
  Complete submission text file 0001104659-25-073623.txt   774304
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40536 | Film No.: 251183187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)